Biosimilar Interchangeability: What You Need to Know for 2019

Posted by Scott Kniaz on Mon, Apr 01, 2019

Christina Corridon co-wrote this blog post with Scott Kniaz.

In the hallways and boardrooms we occupy, there is a lot of talk of interchangeability of biosimilars right now. Despite all the conversation, there doesn’t seem to be a consensus opinion about its relative value or worthiness. To help you to be more knowledgeable around the watercooler and to help inform your own opinions, let’s start from the beginning, define some key terms, explain what the interchangeability hub-bub is all about, and detail why it is a hot topic that you are hearing more and more about now. 


>
Read More